NVCR - Novocure's Chief Science Officer retires March, 21 2019 06:38 AM NovoCure Limited Novocure (NASDAQ:NVCR) Chief Science Officer and Head of R&D, Dr. Eilon Kirson will retire effective May 1, to spend more time with his family.More news on: NovoCure Limited, Healthcare stocks news, Read more ...